Strengthening engagement across India’s healthcare innovation ecosystem, haf.vc, in collaboration with Alkemi Growth Capital, hosted a gathering of healthcare leaders, hospital operators, pharmaceutical executives, entrepreneurs and investors in Hyderabad on November 5, 2026. The event, titled Healthcare Innovation: Founders, Operators and Investors Shaping Indian Healthcare, examined emerging opportunities and the priorities shaping the sector’s future.
The programme featured two panel discussions focused on hospital services and the pharmaceutical industry, alongside presentations by emerging healthcare startups. Discussions covered artificial intelligence (AI), patient-centric care, operational efficiency, pharmaceutical innovation, talent development and the creation of scalable healthcare businesses.
Kalyan Sivalenka, Managing Partner, haf.vc, said, “India’s healthcare ecosystem is at an important inflection point. We are seeing exciting innovation across healthcare delivery, technology and pharmaceutical businesses, but the real opportunity lies in translating these innovations into solutions that can scale and create meaningful impact. At haf.vc, we believe in backing entrepreneurs who are solving critical industry challenges and building businesses for the long term.”
The hospital panel explored how technology, preventive healthcare and operational improvements could reshape patient experiences and healthcare delivery. Dr. Saurabh Lall, COO, KIMS Hospitals, said, “The patient of 2036 won’t come to the hospital for what can be done at home or at a nearby centre. When they do come, they’ll go straight to the OT, supported by preventive medicine, an educated patient and a digital twin.”
Dr GV Rao, Director, AIG Hospitals, highlighted the importance of streamlining hospital processes and improving patient journeys. “Efficiency is measurable. We’re taking the patient journey from 7,000 steps to 250 already. That has impacted our patient experience massively,” he said. He also stressed the importance of retaining clinical expertise while using external capabilities to improve efficiency and scale without compromising quality.
The pharmaceutical panel examined India’s potential to strengthen its global industry position through investment in research and development, manufacturing, technology and skilled talent. Rajeev Nannapaneni, Vice Chairman and CEO, Natco Pharma, discussed the challenges pharmaceutical companies face when entering public markets, particularly the difference between quarterly investor expectations and the industry’s long-term development cycles. He emphasised transparency, financial discipline and responsible leverage as important factors in sustaining growth.
The discussions also highlighted the need to strengthen domestic manufacturing and the country’s research ecosystem through greater investment in scientific education. AI adoption and transparent financial practices were identified as important priorities for the sector. Startup presentations by ePlane, TMTC, Bamboo Box, Medulance, QuickClean and Medvital provided emerging companies with an opportunity to showcase their solutions and interact with investors and industry representatives.
Alka Goel, Founding Partner, Alkemi Growth Capital, said, “The next chapter of India’s healthcare growth will be shaped by businesses that combine strong fundamentals with innovation and execution capabilities. While technology and capital are important growth drivers, sustainable value creation ultimately comes from strong leadership, operational discipline and a clear understanding of market needs.”
The event underlined that healthcare transformation requires more than technological advancement. Skilled talent, effective execution, operational excellence and sustainable business models will be central to developing the next generation of healthcare enterprises. Through this collaboration, haf.vc and Alkemi Growth Capital aim to encourage stronger partnerships between founders, operators and investors and support India’s evolving healthcare ecosystem.